Literature DB >> 35674928

Regulation of DAPK1 by Natural Products: An Important Target in Treatment of Stroke.

Tayebeh Noori1, Samira Shirooie2, Antoni Sureda3,4, Eduardo Sobarzo-Sanchez5, Ahmad Reza Dehpour6,7, Marianela Saldías5, Esra Küpeli Akkol8.   

Abstract

Stroke is a sudden neurological disorder that occurs due to impaired blood flow to an area of the brain. Stroke can be caused by the blockage or rupture of a blood vessel in the brain, called ischemic stroke and hemorrhagic stroke, respectively. Stroke is more common in men than women. Atrial fibrillation, hypertension, kidney disease, high cholesterol and lipids, genetic predisposition, inactivity, poor nutrition, diabetes mellitus, family history and smoking are factors that increase the risk of stroke. Restoring blood flow by repositioning blocked arteries using thrombolytic agents or endovascular therapy are the most effective treatments for stroke. However, restoring circulation after thrombolysis can cause fatal edema or intracranial hemorrhage, and worsen brain damage in a process known as ischemia-reperfusion injury. Therefore, there is a pressing need to find and develop more effective treatments for stroke. In the past, the first choice of treatment was based on natural compounds. Natural compounds are able to reduce the symptoms and reduce various diseases including stroke that attract the attention of the pharmaceutical industry. Nowadays, as a result of the numerous studies carried out in the field of herbal medicine, many useful and valuable effects of plants have been identified. The death-associated protein kinase (DAPK) family is one of the vital families of serine/threonine kinases involved in the regulation of some biological functions in human cells. DAPK1 is the most studied kinase within the DAPKs family as it is involved in neuronal and recovery processes. Dysregulation of DAPK1 in the brain is involved in the developing neurological diseases such as stroke. Natural products can function in a variety of ways, including reducing cerebral edema, reducing brain endothelial cell death, and inhibiting TNFα and interleukin-1β (IL-1β) through regulating the DAPK1 signal against stroke. Due to the role of DAPK1 in neurological disorders, the aim of this article was to investigate the role of DAPK1 in stroke and its modulation by natural compounds.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Natural product; Neurological disorders; Stroke; The death-associated protein kinase 1 (DAPK1)

Mesh:

Substances:

Year:  2022        PMID: 35674928     DOI: 10.1007/s11064-022-03628-7

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   4.414


  136 in total

1.  Falls classification using tri-axial accelerometers during the five-times-sit-to-stand test.

Authors:  Emer P Doheny; Cathal Walsh; Timothy Foran; Barry R Greene; Chie Wei Fan; Clodagh Cunningham; Rose Anne Kenny
Journal:  Gait Posture       Date:  2013-06-21       Impact factor: 2.840

2.  Heart disease and stroke statistics--2015 update: a report from the American Heart Association.

Authors:  Dariush Mozaffarian; Emelia J Benjamin; Alan S Go; Donna K Arnett; Michael J Blaha; Mary Cushman; Sarah de Ferranti; Jean-Pierre Després; Heather J Fullerton; Virginia J Howard; Mark D Huffman; Suzanne E Judd; Brett M Kissela; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Simin Liu; Rachel H Mackey; David B Matchar; Darren K McGuire; Emile R Mohler; Claudia S Moy; Paul Muntner; Michael E Mussolino; Khurram Nasir; Robert W Neumar; Graham Nichol; Latha Palaniappan; Dilip K Pandey; Mathew J Reeves; Carlos J Rodriguez; Paul D Sorlie; Joel Stein; Amytis Towfighi; Tanya N Turan; Salim S Virani; Joshua Z Willey; Daniel Woo; Robert W Yeh; Melanie B Turner
Journal:  Circulation       Date:  2014-12-17       Impact factor: 29.690

3.  Fall risk screening in the elderly: A comparison of the minimal chair height standing ability test and 5-repetition sit-to-stand test.

Authors:  Nadia Reider; Catherine Gaul
Journal:  Arch Gerontol Geriatr       Date:  2016-03-15       Impact factor: 3.250

4.  Technique to improve chronic motor deficit after stroke.

Authors:  E Taub; N E Miller; T A Novack; E W Cook; W C Fleming; C S Nepomuceno; J S Connell; J E Crago
Journal:  Arch Phys Med Rehabil       Date:  1993-04       Impact factor: 3.966

5.  Stroke Neurologist's Perspective on the New Endovascular Trials.

Authors:  James C Grotta; Werner Hacke
Journal:  Stroke       Date:  2015-05-05       Impact factor: 7.914

6.  Abnormal muscle activation characteristics associated with loss of dexterity after stroke.

Authors:  C G Canning; L Ada; N J O'Dwyer
Journal:  J Neurol Sci       Date:  2000-05-01       Impact factor: 3.181

7.  Histological stroke clot analysis after thrombectomy: Technical aspects and recommendations.

Authors:  S Staessens; S Fitzgerald; T Andersson; F Clarençon; F Denorme; M J Gounis; W Hacke; D S Liebeskind; I Szikora; Acgm van Es; W Brinjikji; K M Doyle; S F De Meyer
Journal:  Int J Stroke       Date:  2019-11-03       Impact factor: 5.266

Review 8.  What is the evidence for physical therapy poststroke? A systematic review and meta-analysis.

Authors:  Janne Marieke Veerbeek; Erwin van Wegen; Roland van Peppen; Philip Jan van der Wees; Erik Hendriks; Marc Rietberg; Gert Kwakkel
Journal:  PLoS One       Date:  2014-02-04       Impact factor: 3.240

9.  Sex differences in coronary heart disease and stroke mortality: a global assessment of the effect of ageing between 1980 and 2010.

Authors:  Sophie H Bots; Sanne A E Peters; Mark Woodward
Journal:  BMJ Glob Health       Date:  2017-03-27

10.  Total small vessel disease score and risk of recurrent stroke: Validation in 2 large cohorts.

Authors:  Kui Kai Lau; Linxin Li; Ursula Schulz; Michela Simoni; Koon Ho Chan; Shu Leong Ho; Raymond Tak Fai Cheung; Wilhelm Küker; Henry Ka Fung Mak; Peter M Rothwell
Journal:  Neurology       Date:  2017-05-17       Impact factor: 9.910

View more
  1 in total

1.  Spectrum effect correlation of yangyin tongnao granules on cerebral ischemia-reperfusion injury rats.

Authors:  Yangyang Zhang; Li Yu; Jiehong Yang; Zhishan Ding; Yu He; Haitong Wan
Journal:  Front Pharmacol       Date:  2022-08-09       Impact factor: 5.988

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.